Captrust Financial Advisors Tiziana Life Sciences LTD Transaction History
Captrust Financial Advisors
- $30.9 Billion
- Q2 2024
A detailed history of Captrust Financial Advisors transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Captrust Financial Advisors holds 34,600 shares of TLSA stock, worth $38,406. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,600Holding current value
$38,406% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TLSA
# of Institutions
27Shares Held
929KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA220KShares$243,6680.0% of portfolio
-
Hsbc Holdings PLC London, X0125KShares$139,1550.0% of portfolio
-
Morgan Stanley New York, NY111KShares$122,6720.0% of portfolio
-
Zhang Financial LLC55.9KShares$62,0340.0% of portfolio
-
Ausdal Financial Partners, Inc. Davenport, IA55.7KShares$61,8270.01% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $114M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...